3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States

By afschroeder • June 12, 2025

Eleid MF, Krishnaswamy A, Kapadia S, Yadav P, Rajagopal V, Makkar R, Stinis C, Chetcuti S, Morse A, Frisoli T, Frangieh AH, Abbas AE, Whisenant B, O'Neill WW, Guerrero ME, Rodriguez E, Kodali S, Ailawadi G, Rihal CS. 3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States. JACC Cardiovasc Interv. 2025 Jun 9;18(11):1454-1466. doi: 10.1016/j.jcin.2025.03.017. PMID: 40500016.

Tags: bioprosthetic mitral degeneration, Cardiology/Epi, Cedars Sinai DoM, mitral valve reintervention, mitral valve-in-valve procedure, Publications, Society for Thoracic Surgeons, Transcatheter Valve Therapy Registry, transseptal approach

Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis

Budoff MJ, de Oliveira Otto MC, Li XS, Lee Y, Wang M, Lai HTM, Lemaitre RN, Pratt A, Tang WHW, Psaty BM, Siscovick DS, Hazen[...]

Exploring depression treatment response by using polygenic risk scoring across diverse populations

Lapinska S, Pimplaskar A, Shi Z, Ding Y, Frydman-Gani C, Hou K, Venkateswaran V, Boulier K, Olde Loohuis LM, Pasaniuc B. Exploring depression treatment response[...]

A molecular tango between chromatin and metabolites orchestrates a feedback switch for alcohol consumption

Schmidt HM, Tarling EJ, Vallim TQA. A molecular tango between chromatin and metabolites orchestrates a feedback switch for alcohol consumption. Proc Natl Acad Sci U[...]